Cargando…

Weakly-supervised learning for lung carcinoma classification using deep learning

Lung cancer is one of the major causes of cancer-related deaths in many countries around the world, and its histopathological diagnosis is crucial for deciding on optimum treatment strategies. Recently, Artificial Intelligence (AI) deep learning models have been widely shown to be useful in various...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanavati, Fahdi, Toyokawa, Gouji, Momosaki, Seiya, Rambeau, Michael, Kozuma, Yuka, Shoji, Fumihiro, Yamazaki, Koji, Takeo, Sadanori, Iizuka, Osamu, Tsuneki, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283481/
https://www.ncbi.nlm.nih.gov/pubmed/32518413
http://dx.doi.org/10.1038/s41598-020-66333-x
_version_ 1783544308568162304
author Kanavati, Fahdi
Toyokawa, Gouji
Momosaki, Seiya
Rambeau, Michael
Kozuma, Yuka
Shoji, Fumihiro
Yamazaki, Koji
Takeo, Sadanori
Iizuka, Osamu
Tsuneki, Masayuki
author_facet Kanavati, Fahdi
Toyokawa, Gouji
Momosaki, Seiya
Rambeau, Michael
Kozuma, Yuka
Shoji, Fumihiro
Yamazaki, Koji
Takeo, Sadanori
Iizuka, Osamu
Tsuneki, Masayuki
author_sort Kanavati, Fahdi
collection PubMed
description Lung cancer is one of the major causes of cancer-related deaths in many countries around the world, and its histopathological diagnosis is crucial for deciding on optimum treatment strategies. Recently, Artificial Intelligence (AI) deep learning models have been widely shown to be useful in various medical fields, particularly image and pathological diagnoses; however, AI models for the pathological diagnosis of pulmonary lesions that have been validated on large-scale test sets are yet to be seen. We trained a Convolution Neural Network (CNN) based on the EfficientNet-B3 architecture, using transfer learning and weakly-supervised learning, to predict carcinoma in Whole Slide Images (WSIs) using a training dataset of 3,554 WSIs. We obtained highly promising results for differentiating between lung carcinoma and non-neoplastic with high Receiver Operator Curve (ROC) area under the curves (AUCs) on four independent test sets (ROC AUCs of 0.975, 0.974, 0.988, and 0.981, respectively). Development and validation of algorithms such as ours are important initial steps in the development of software suites that could be adopted in routine pathological practices and potentially help reduce the burden on pathologists.
format Online
Article
Text
id pubmed-7283481
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72834812020-06-15 Weakly-supervised learning for lung carcinoma classification using deep learning Kanavati, Fahdi Toyokawa, Gouji Momosaki, Seiya Rambeau, Michael Kozuma, Yuka Shoji, Fumihiro Yamazaki, Koji Takeo, Sadanori Iizuka, Osamu Tsuneki, Masayuki Sci Rep Article Lung cancer is one of the major causes of cancer-related deaths in many countries around the world, and its histopathological diagnosis is crucial for deciding on optimum treatment strategies. Recently, Artificial Intelligence (AI) deep learning models have been widely shown to be useful in various medical fields, particularly image and pathological diagnoses; however, AI models for the pathological diagnosis of pulmonary lesions that have been validated on large-scale test sets are yet to be seen. We trained a Convolution Neural Network (CNN) based on the EfficientNet-B3 architecture, using transfer learning and weakly-supervised learning, to predict carcinoma in Whole Slide Images (WSIs) using a training dataset of 3,554 WSIs. We obtained highly promising results for differentiating between lung carcinoma and non-neoplastic with high Receiver Operator Curve (ROC) area under the curves (AUCs) on four independent test sets (ROC AUCs of 0.975, 0.974, 0.988, and 0.981, respectively). Development and validation of algorithms such as ours are important initial steps in the development of software suites that could be adopted in routine pathological practices and potentially help reduce the burden on pathologists. Nature Publishing Group UK 2020-06-09 /pmc/articles/PMC7283481/ /pubmed/32518413 http://dx.doi.org/10.1038/s41598-020-66333-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kanavati, Fahdi
Toyokawa, Gouji
Momosaki, Seiya
Rambeau, Michael
Kozuma, Yuka
Shoji, Fumihiro
Yamazaki, Koji
Takeo, Sadanori
Iizuka, Osamu
Tsuneki, Masayuki
Weakly-supervised learning for lung carcinoma classification using deep learning
title Weakly-supervised learning for lung carcinoma classification using deep learning
title_full Weakly-supervised learning for lung carcinoma classification using deep learning
title_fullStr Weakly-supervised learning for lung carcinoma classification using deep learning
title_full_unstemmed Weakly-supervised learning for lung carcinoma classification using deep learning
title_short Weakly-supervised learning for lung carcinoma classification using deep learning
title_sort weakly-supervised learning for lung carcinoma classification using deep learning
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283481/
https://www.ncbi.nlm.nih.gov/pubmed/32518413
http://dx.doi.org/10.1038/s41598-020-66333-x
work_keys_str_mv AT kanavatifahdi weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT toyokawagouji weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT momosakiseiya weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT rambeaumichael weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT kozumayuka weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT shojifumihiro weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT yamazakikoji weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT takeosadanori weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT iizukaosamu weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning
AT tsunekimasayuki weaklysupervisedlearningforlungcarcinomaclassificationusingdeeplearning